Q-13
ESTABLISHMENT OF COLLABORATIVE DRUG THERAPY MANAGEMENT PHARMACIST
INTERVENTIONS IN AN INTERDISCIPLINARY HIV PRIMARY CARE CLINIC
Arcebido R*, Rubin R, Cha A
The Brooklyn Hospital Center, Department of Pharmacy, Brooklyn, NY 11201
Objective:
Since the first reported cases of human immunodeficiency virus (HIV) in the early 1980s and the limited
choices of antiretroviral (ARV) therapy, the understanding of this disease and tailoring of treatment has
grown exponentially. As a result, HIV-positive patients are living longer and the increased incidence of
comorbidities and their management demands attention. Several studies demonstrate collaborative drug
therapy management (CDTM) and pharmacist interventions have led to positive patient outcomes in clinics
focusing on diabetes, hypertension and lipids. Although CDTM specifically has not been studied in HIV
clinics, the effects of pharmacists’ intervention on patient outcomes in this area has shown to significantly
improve CD4 lymphocyte counts, viral loads and drug-related toxicities. However, studies evaluating the
role of an HIV pharmacist in managing ARV concurrently with chronic disease states as part of a primary
care outpatient team are lacking. The purpose of this study is to evaluate the frequency and types of
interventions made by a pharmacist as part of an interdisciplinary healthcare team in a hospital-affiliated
outpatient HIV primary care clinic.
Methods:
This is a retrospective data analysis to analyze the types and frequency of clinical interventions made by a
pharmacist as part of an interdisciplinary healthcare team in an urban, hospital-affiliated HIV primary care
clinic. Adult patients > 21 years of age, diagnosed with HIV, whose healthcare is provided by The
Brooklyn Hospital Center’s Program for AIDS Treatment and Health (PATH) Center outpatient clinic are
included in this study. In compliance with the New York State Board of Pharmacy outcome metrics for
pharmacy managed CDTM programs, interventions regarding medication indication, effectiveness, safety,
adherence and cost avoidance will be assessed. These outcomes will be quantified through retrospective
review of medication management notes documented in a secure, online database called MedKeeper
entered from January 2011 to December 2012. One pharmacist will review each medication management
note and categorize the type of each intervention that occurred during the clinic visit. The number of
interventions will be tallied without the use of patient identifiers. Data will be reported by month and
analyzed using descriptive statistics.
Results:
To date, two years of the described CDTM pharmacist-led intervention data have been reviewed. Results
will be presented at the conference pending further data analysis.
Conclusions:
It is anticipated that this project will demonstrate a role for an ambulatory care clinical pharmacist in
outpatient HIV primary care clinics.